Lawrenceville, NJ, United States of America

Theodore C Jessop

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2009-2013.

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 85.7

CIPO Patents = 2

EPO Patents = 3

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 29(Granted Patents)

Company Filing History:

7 out of 89

Lexicon Pharmaceuticals, Inc.

patents

Years Active: 2009-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8404732 - Methods of treating ulcerative colitis (2013-03-26),

2. 8093267 - Methods of treating rheumatoid arthritis (2012-01-10),

3. 8093246 - O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer (2012-01-10),

4. 8093245 - 4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use (2012-01-10),

5. 7825142 - Heterocyclic compounds, compositions comprising them and methods of their use (2010-11-02),

6. 7649098 - Imidazole-based compounds, compositions comprising them and methods of their use (2010-01-19),

7. 7598280 - Heterocyclic compounds, compositions comprising them and methods of their use (2009-10-06),

Title: The Innovations of Theodore C. Jessop

Introduction

Theodore C. Jessop is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ulcerative colitis and other diseases. With a total of 7 patents to his name, Jessop's work has had a meaningful impact on medical science.

Latest Patents

Jessop's latest patents include innovative methods for treating ulcerative colitis. These methods utilize imidazole-based compounds that inhibit S1P lyase, providing new avenues for managing this challenging condition. Additionally, he has developed 4-amino-1H-pyrimidin-2-one-based compounds, which are disclosed for their potential in treating, preventing, and managing various diseases and disorders.

Career Highlights

Theodore C. Jessop is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic solutions.

Collaborations

Jessop has collaborated with esteemed colleagues, including David John Augeri and Kenneth Gordon Carson, to further enhance the scope and impact of his inventions.

Conclusion

Theodore C. Jessop's contributions to the field of pharmaceuticals exemplify the spirit of innovation and dedication to improving healthcare. His patents and ongoing research continue to pave the way for advancements in medical treatments.